Newsroom
Latest News
Washington, DC – Just hours after being named the Chair of the House Energy and Commerce Committee's Oversight and Investigations Committee, U.S. Rep. Diana DeGette (D-CO) announced today the hiring of Dr. Manik Roy as her new Climate Change and Environment Policy Director.
Washington, D.C. – Congresswoman Diana DeGette (D-CO), along with Representatives Eliot Engel (D-NY), Susan Brooks (R-IN), and Jaime Herrera Beutler (R-WA) have introduced H.R. 501, the Poison Center Network Enhancement Act of 2019, to assist with potential poison exposures and help combat the national opioid epidemic.
Washington, DC – Today, U.S. Reps. Diana DeGette (CO-01), Ed Perlmutter (CO-07), Jason Crow (CO-06) and Joe Neguse (CO-02) released a joint statement calling on Senate Republicans and President Trump to immediately act to end the partial government shutdown:
Rep. Diana DeGette returned to Washington as the most senior member of Colorado's congressional delegation and in the political majority.
But tempering the Democratic Party's newfound control in the House is the government shutdown, now entering its third week.
Some of Colorado's Congressional representatives are refusing to accept their paychecks during the government shutdown. Those include Rep. Diana DeGette, Rep. Scott Tipton and Rep. Doug Lamborn.
Washington, DC – Following is a statement from U.S. Rep. Diana DeGette (D-CO) on the president's visit to McAllen, TX today. DeGette was one of two dozen House members who visited McAllen, TX in June to get a firsthand look at the situation on the ground there.
Washington, DC – Congresswoman Diana DeGette (D-CO) released the following statement after President Trump's televised Oval Office address to the nation:
Washington, D.C. – U.S. Rep. Diana DeGette (D-CO) today led a bicameral group of more than 200 members of Congress in calling on the Trump administration to rescind a newly proposed rule that seeks to limit women's access to abortion care.
Washington, DC – The U.S. House of Representatives today approved legislation aimed at improving and speeding up the federal Food and Drug Administration's process for evaluating new over-the-counter (OTC) medications to determine whether they are safe enough to be sold to consumers without a prescription.